News | July 09, 2007

Partnership to Build First Proton Therapy Center in Illinois

July 10, 2007 - Cancer patients in Illinois will soon have access to proton therapy, a highly advanced form of radiation treatment, at a new center to be located in DuPage County. A Chicago-area physicians group, Radiation Oncology Consultants Limited (ROCL), Central DuPage Hospital, Winfield and ProCure Treatment Centers Inc., Bloomington, IN, announced today that they will collaborate to make this treatment available to patients in need.

The new four-room center will be the first to open in Illinois, and only the eighth in the country. The hospital filed a letter of intent late yesterday with the Illinois Health Facilities Planning Board and construction crews will be able to break ground for the center within a month of the regulatory board granting its approval of the project. If approval is received by this fall, the center would open to treat patients in January 2010.

ProCure Treatment Centers will manage the construction, operation and maintenance plan for the $125 million, 58,000-square-foot facility that will have the capacity to accommodate up to 1,500 patients per year. The company anticipates the development of the treatment center will create approximately 100 full-time jobs and 850 temporary positions for construction and start-up operations. Illinois-based contractors will be used to construct the facility.
ROCL physicians chose to partner with ProCure following an exhaustive three-year search to identify and evaluate the best way to provide their patients access to proton therapy. ROCL and ProCure, in turn, selected Central DuPage Hospital, a nationally recognized institution.

For more information: www.chicagocancer.com., www.cdh.org, www.ProCureCenters.com

Related Content

Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Proton Treatment System
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...